
On a World Tour
Trump’s Big Trip to Asia
Skimm’d by: Aryanna Prasad Bhullar and Maria Corpus
What’s going on: President Donald Trump’s 48-hour Asia tour kicked off today. It will include Trump’s second visit to China this year, albeit with a Jensen Huang-sized hole in his entourage. It's his first international trip since his party's defeat in the midterms. While the loss isn't "ruin the tour" level, analysts say it weakens Trump's authority on the global stage and could spur a "renewed focus on foreign policy.” The three-day trip kicks off today in Manila, Philippines at the Association of Southeast Asian Nations (ASEAN) annual summit, where Trump is expected to sign a trade agreement with Thailand and meet leaders from India, Japan, and Australia in the first-ever Quad meeting. Then he heads to Shenzhen, China, where topics like rising energy costs and the war in Iran will be top of mind. He’ll also meet with Chinese President Xi Jinping and Russian President Vladimir Putin in a trilateral summit between the world’s greatest nuclear powers. Talk about a packed agenda.
Expectation vs. reality: Some world leaders have high hopes for the tour, like Australian Prime Minister Anthony Albanese, who wants to “see a de-escalation in the conflicts that are around the world.” But mostly, this trip appears to be about the vibes. Political analysts say the US will lobby at both summits to further its AI dominance in the region, and the trilateral summit may be more photo op than roundtable. And while there’s plenty to discuss — from the war in Iran to the conflict between Russia and Ukraine — experts don’t anticipate Putin or Jinping to budge on either topic. (Maybe First Lady Melania Trump will have better luck getting something done.)
Related: US Intelligence Reportedly Uncovered Iran’s Plan To Detonate a “Dirty Bomb” in Washington, DC (CNN)
The News in 6
🗞️ Customers from at least five major banks, including Bank of America and JPMorgan Chase, experienced widespread service outages on Monday, with Chase Bank citing a software bug. Is everything breaking down this month?
🗞️ United Airlines says it suffered a systemwide outage on Monday, affecting departing flights. It comes just days after the Federal Aviation Administration's nationwide ground stop.
🗞️ Lindsay Clancy has a new trial date of March 29, 2027, after a hung jury ended the first trial earlier this year. Despite speculation that Clancy's case might be retried as manslaughter or second-degree murder, the charges remain first-degree murder.
🗞️ New York Mayor Zohran Mamdani announced he’s shutting down the NYPD’s Strategic Response Group, which civil rights advocates have long criticized as being aggressive during protests.
🗞️ Alexa, play “Where Is My Husband!” Raye scored the most Grammy nominations with 11, followed by Rosalía with nine. Also nominated: Dolly Parton, who scored three posthumous nods.
🗞️ The US women’s national hockey team beat Canada 6-2 in the World Championship’s gold medal game — the first time a US team has bagged Olympic and world titles in the same year. Puck yeah.
In Our Rotation
Did someone say matching holiday pajamas?
Knix is taking up to 50% off everything for Black Friday, but you can get in early today with code SKIMMEARLY. We could go for some comfy lounge pants.
Higher Ed
International Students Slam Their Laptops Shut
Skimm’d by: Kate Preziosi and Samantha Darby
What's going on: New data revealed an eye-popping 9% decline in enrollment at US colleges among preexisting international students in the last year. The survey of more than 800 US schools also found that new international student enrollment tanked by 15%, on the heels of an 18% drop in the year prior. Since the beginning of President Donald Trump’s second term, the administration has abruptly canceled international student visas, bottlenecked the application process, and introduced new rules that make it harder to get a job upon graduation. Taken together, these policies are having the intended chilling effect on student communities. The drop among existing international students is particularly noteworthy. As one education expert told The New York Times, “These are people who’ve already started, and they’ve said, ‘No, the risk is too high. I’m not going back.’”
So that faculty hiring freeze is...: Probably not lifting anytime soon, no. International students typically pay full tuition, which schools rely on to subsidize domestic student tuition, new programs, faculty positions, and student services. But the international student exodus may be about more than just policy. Anti-immigration rhetoric has surged online in recent years as many tech platforms have rolled back content moderation. Earlier this year, Republican midterm candidate Bo French fueled racism on campuses by posting a photo of South Asian students at a University of Texas football game with a caption that read in part: “The problem is now obviously far worse than anyone imagined.” And the hit to America’s brand abroad might be permanent. “No one aspires to send their kids to get educated in the US,” one rep for an association of professors told the Associated Press. “It feels like an unsafe place.”
Related: Federal Judge Tosses Out Trump Admin’s Visa Limits On International Students (Politico)
Not Shaken, But Stirred
The Search for 007 Is Complete
Skimm’d by: Erika W. Smith and Maria Corpus
What's going on: Seven years after Daniel Craig turned in his 007 badge, the James Bond franchise has its new spy: Robert Pattinson. Whether you think of him as Edward Cullen, Batman, or The Odyssey villain Antinous (with the viral “Somebody get these beggars out of here” line), you definitely know him. According to The New York Times, five actors — Pattinson, Nicholas Hoult, Jack Lowden, Josh O’Connor, and Callum Turner — screen tested for Bond in late October. The process reportedly involved stunts and dialogue — and if Henry Cavill's 2005 Bond audition was anything to go by, maybe a semi-nude scene, too (and you thought your last job search was intense). Director Denis Villeneuve (who worked with Pattinson on Dune: Part Three) and the film’s producers made the final call. According to The Hollywood Reporter, Pattinson and the rest of the final five got the news on Sunday, one day before it went public. In a statement, Pattinson called stepping into 007’s Savile Row suits “the honor of a lifetime.”
Cue the discourse: A Bond casting always inspires snark and think pieces (remember the backlash against Daniel Craig?). As GQ puts it, Pattinson is “both a particularly inspired and obvious choice.” He’s another white dude, which will likely disappoint those who advocated for a Black and/or female Bond. Idris Elba and Regé-Jean Page were once rumored to be in the running, though the five who screen tested are all white men. Unlike Craig when he was cast, Pattinson is also already a household name, with roles in seemingly every big franchise. Yet his penchant for playing “weird little guys” in art house movies like The Lighthouse and Mickey 17 has made him beloved by cinephiles and suggests he can stand out from all the other Bonds before him. (Exactly how many? Test your knowledge in our quiz below.) We’ll have to wait a while before we see his take on Bond: The new 007 is unlikely to hit the big screen before 2028. That’s plenty of time to perfect your martini order.
Related: Idris Elba Says He Was Never Really in the Running To Play Bond (CNN)
Quick Hits
🍽️ If you want to save the complicated cooking for next week, here are nine hearty winter recipes that are filling and simple. Sign us up for the mushroom risotto.
🎢 Mattel announced that its forthcoming theme park will have a Barbie dreamhouse-inspired hotel with a giant pink tower. Come on, Barbie, let's go party.
🌱 What do garlic, broccoli, and bread all have in common? They are all potential, lesser-known triggers for bloating (and all for different reasons).
👟 File this under trends that can stay in the past: the wedge sneaker. Yes, millennials, this and five other controversial shoes are making a comeback.
👒 You need to see the enormous feathery hat Cardi B wore to the Baby2Baby Gala. That's one way to say, "I am the drama."
💅 ‘Tis the season for rich, textured nails. We're here for the velvety matte and fuzzy sweater trends.
Skimm This
Give us your best skimm:

We want your funniest take on this week's photo in 20 words or fewer. We'll pick our top three, you'll vote for your favorite in Thursday's Daily Skimm, and we'll announce the winner Friday.
This week: The Office's Kate Flannery stopped by The Jennifer Hudson Show to support her real-life bestie, Jane Lynch. Somewhere, a sitcom writer just got an idea.
On Our Calendar
Tuesday, November 17
📚 Biden’s presidential memoir hits bookstores
Former President Joe Biden’s book Promise Me, America, covers his four years in office, including (for the first time) his words on why he dropped out of the 2024 presidential race.
📖 Peculiar Stars hits bookstores
Rebecca Yarros is taking a break from dragons. Her new romance novel strands a woman on a deserted island, with a ship's crew and her fiancé’s cousin, after a cyclone hits. Catastrophic weather x entanglement drama? Sign us up.
☕ Starbucks Red Cup Day
Order a holiday drink today and score a free reusable red cup. They tend to disappear within hours, so have your choice ready. PS… here’s the TL;DR on what’s worth trying from the new holiday menu.
Psst... See what else is happening this week so you never miss a moment.
What I’m Keeping Tabs On

Ali here, Senior Commerce Director. As we inch closer to my team’s biggest event of the year (Cyber Week), I've started a list of things I plan to buy. My wallet is currently placed out of reach until then, but here’s what I’ve queued up so far:
The perfect button-down. I’ve watched too many reels on how to button one in a cool way, so consider me influenced.
Sunglasses I can run in. When you spend over $89, you get 20% off with code SAVINGS20.
The holiday sweater I want to wear to Christmas dinner.
The insoles I’m praying will solve my current foot pain. I’ve upped my daily step count, but boy do I feel it.
In Our Rotation
Bring a few pints of festive ice cream to the holiday potluck — no one will say no to Black Tie Tiramisu.
A warm, woodsy candle to ease you into holiday scents.
KNOW IT ALL
How many actors have portrayed James Bond since the first movie in 1962?

Ease into your day with Typeshift, the word-building game. Start playing.
SPONSORED BY ELI LILLY AND COMPANY
Wake-Up Call
This promotional information is intended for US Residents ages 18 and older.
Click here to view Indications and Safety Summary with Warnings.
Shaquille O’Neal has always played big. But he was also exhausted for way longer than he let on due to loud snoring, choking, and gasping for air while sleeping.
Turns out, those can be signs of moderate-to-severe obstructive sleep apnea (OSA), and he’s one of an estimated 24 million affected adults in the US, many of whom are living with obesity.
That’s why the NBA legend takes Zepbound® (tirzepatide), the first and only prescription medicine for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound is used along with a reduced-calorie diet and increased physical activity. If any of this sounds familiar, it may be worth a conversation with a doctor.
INDICATIONS AND SAFETY SUMMARY WITH WARNINGS
Zepbound® (ZEHP-bownd) is an injectable prescription medicine used with a reduced-calorie diet and increased physical activity to help adults with:
obesity, or some adults with overweight who also have weight-related medical problems, to lose excess body weight and keep the weight off.
moderate-to-severe obstructive sleep apnea (OSA) and obesity to improve their OSA.
Zepbound contains tirzepatide and should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines. It is not known if Zepbound is safe and effective for use in children.
Warnings - Zepbound may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.
• Do not use Zepbound if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).
• Do not use Zepbound if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Do not use Zepbound if you have had a serious allergic reaction to tirzepatide or any of the ingredients in Zepbound.
KwikPen®: Do not share your KwikPen with other people, even if the pen needle has been changed. You may give other people a serious infection or get a serious infection from them.
Zepbound may cause serious side effects, including:
Severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Zepbound. Tell your healthcare provider if you have stomach problems that are severe or will not go away.
Dehydration leading to kidney problems. Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away.
Gallbladder problems. Gallbladder problems have happened in some people who use Zepbound. Tell your healthcare provider right away if you get symptoms of gallbladder problems, which may include pain in your upper stomach (abdomen), fever, yellowing of skin or eyes (jaundice), or clay-colored stools.
Inflammation of the pancreas (pancreatitis). Stop using Zepbound and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. You may feel the pain from your abdomen to your back.
Serious allergic reactions. Stop using Zepbound and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, or very rapid heartbeat.
Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Zepbound with medicines that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, mood changes, hunger, weakness or feeling jittery.
Changes in vision in patients with type 2 diabetes. Tell your healthcare provider if you have changes in vision during treatment with Zepbound.
Food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). Zepbound may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your healthcare providers that you are taking Zepbound before you are scheduled to have surgery or other procedures.
Common side effects
The most common side effects of Zepbound include nausea, diarrhea, vomiting, constipation, stomach (abdominal) pain, indigestion, injection site reactions, feeling tired, allergic reactions, belching, hair loss, and heartburn. These are not all the possible side effects of Zepbound. Talk to your healthcare provider about any side effect that bothers you or doesn’t go away.
Tell your doctor if you have any side effects. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.
Before using Zepbound
• Your healthcare provider should show you how to use Zepbound before you use it for the first time.
• Talk to your healthcare provider about low blood sugar and how to manage it. Tell your healthcare provider if you are taking medicines to treat diabetes including an insulin or sulfonylurea.
• If you take birth control pills by mouth, talk to your healthcare provider before you use Zepbound. Birth control pills may not work as well while using Zepbound. Your healthcare provider may recommend another type of birth control for 4 weeks after you start Zepbound and for 4 weeks after each increase in your dose of Zepbound.
Review these questions with your healthcare provider:
❑ Do you have other medical conditions, including problems with your pancreas, or severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems digesting food?
❑ Do you take diabetes medicines, such as insulin or sulfonylureas?
❑ Do you have a history of diabetic retinopathy?
❑ Are you scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation)?
❑ Do you take any other prescription medicines or over-the-counter drugs, vitamins, or herbal supplements?
❑ Are you pregnant, plan to become pregnant, breastfeeding, or plan to breastfeed? Zepbound may harm your unborn baby. Tell your healthcare provider if you become pregnant while using Zepbound. Zepbound may pass into your breast milk. You should talk with your healthcare provider about the best way to feed your baby while using Zepbound.
• Pregnancy Exposure Registry: There is a pregnancy exposure registry for women who have taken Zepbound during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. Talk to your healthcare provider about how you can take part in this registry, or you may call 1-844-524-0039 or email at MILEregistry@thermofisher.com or visit https://pregnancyregistry.lilly.com/zepbound.
How to take
Read the Instructions for Use that come with Zepbound.
Use Zepbound exactly as your healthcare provider says.
Use Zepbound with a reduced-calorie diet and increased physical activity.
Inject Zepbound under the skin (subcutaneously) of your stomach (abdomen), thigh, or have another person inject in the back of the upper arm. Do not inject ZEPBOUND into a muscle (intramuscularly) or vein (intravenously).
Use Zepbound 1 time each week, at any time of the day.
Change (rotate) your injection site with each weekly injection. Do not use the same site for each injection.
If you take too much Zepbound, call your healthcare provider, call the Poison Help line at 1-800-222-1222 or go to the nearest hospital emergency room right away.
Zepbound is approved as a 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg injection.
Learn more
Zepbound is a prescription medicine. For more information, call 1-800-LillyRx (1-800-545-5979) or go to www.zepbound.lilly.com.
This summary provides basic information about Zepbound but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare provider about Zepbound and how to take it. Your healthcare provider is the best person to help you decide if Zepbound is right for you.
ZP CON BS 01SEP2026
Zepbound®, its delivery device base and KwikPen® are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
CMAT-45347 10/2026
© Lilly USA, LLC 2026. All rights reserved.
Do not reply to this email. If you have a medical emergency please call 911 or go to your nearest medical facility. If you have a question about a Lilly product, please call 1-800-LillyRx (1-800-545-5979)
PS: This is a sponsored post by Eli Lilly and Company. All rights reserved.

On a World Tour
Trump’s Big Trip to Asia
Skimm’d by: Aryanna Prasad Bhullar and Maria Corpus
What’s going on: President Donald Trump’s 48-hour Asia tour kicked off today. It will include Trump’s second visit to China this year, albeit with a Jensen Huang-sized hole in his entourage. It's his first international trip since his party's defeat in the midterms. While the loss isn't "ruin the tour" level, analysts say it weakens Trump's authority on the global stage and could spur a "renewed focus on foreign policy.” The three-day trip kicks off today in Manila, Philippines at the Association of Southeast Asian Nations (ASEAN) annual summit, where Trump is expected to sign a trade agreement with Thailand and meet leaders from India, Japan, and Australia in the first-ever Quad meeting. Then he heads to Shenzhen, China, where topics like rising energy costs and the war in Iran will be top of mind. He’ll also meet with Chinese President Xi Jinping and Russian President Vladimir Putin in a trilateral summit between the world’s greatest nuclear powers. Talk about a packed agenda.
Expectation vs. reality: Some world leaders have high hopes for the tour, like Australian Prime Minister Anthony Albanese, who wants to “see a de-escalation in the conflicts that are around the world.” But mostly, this trip appears to be about the vibes. Political analysts say the US will lobby at both summits to further its AI dominance in the region, and the trilateral summit may be more photo op than roundtable. And while there’s plenty to discuss — from the war in Iran to the conflict between Russia and Ukraine — experts don’t anticipate Putin or Jinping to budge on either topic. (Maybe First Lady Melania Trump will have better luck getting something done.)
Related: US Intelligence Reportedly Uncovered Iran’s Plan To Detonate a “Dirty Bomb” in Washington, DC (CNN)
The News in 6
🗞️ Customers from at least five major banks, including Bank of America and JPMorgan Chase, experienced widespread service outages on Monday, with Chase Bank citing a software bug. Is everything breaking down this month?
🗞️ United Airlines says it suffered a systemwide outage on Monday, affecting departing flights. It comes just days after the Federal Aviation Administration's nationwide ground stop.
🗞️ Lindsay Clancy has a new trial date of March 29, 2027, after a hung jury ended the first trial earlier this year. Despite speculation that Clancy's case might be retried as manslaughter or second-degree murder, the charges remain first-degree murder.
🗞️ New York Mayor Zohran Mamdani announced he’s shutting down the NYPD’s Strategic Response Group, which civil rights advocates have long criticized as being aggressive during protests.
🗞️ Alexa, play “Where Is My Husband!” Raye scored the most Grammy nominations with 11, followed by Rosalía with nine. Also nominated: Dolly Parton, who scored three posthumous nods.
🗞️ The US women’s national hockey team beat Canada 6-2 in the World Championship’s gold medal game — the first time a US team has bagged Olympic and world titles in the same year. Puck yeah.
Higher Ed
International Students Slam Their Laptops Shut
Skimm’d by: Kate Preziosi and Samantha Darby
What's going on: New data revealed an eye-popping 9% decline in enrollment at US colleges among preexisting international students in the last year. The survey of more than 800 US schools also found that new international student enrollment tanked by 15%, on the heels of an 18% drop in the year prior. Since the beginning of President Donald Trump’s second term, the administration has abruptly canceled international student visas, bottlenecked the application process, and introduced new rules that make it harder to get a job upon graduation. Taken together, these policies are having the intended chilling effect on student communities. The drop among existing international students is particularly noteworthy. As one education expert told The New York Times, “These are people who’ve already started, and they’ve said, ‘No, the risk is too high. I’m not going back.’”
So that faculty hiring freeze is...: Probably not lifting anytime soon, no. International students typically pay full tuition, which schools rely on to subsidize domestic student tuition, new programs, faculty positions, and student services. But the international student exodus may be about more than just policy. Anti-immigration rhetoric has surged online in recent years as many tech platforms have rolled back content moderation. Earlier this year, Republican midterm candidate Bo French fueled racism on campuses by posting a photo of South Asian students at a University of Texas football game with a caption that read in part: “The problem is now obviously far worse than anyone imagined.” And the hit to America’s brand abroad might be permanent. “No one aspires to send their kids to get educated in the US,” one rep for an association of professors told the Associated Press. “It feels like an unsafe place.”
Related: Federal Judge Tosses Out Trump Admin’s Visa Limits On International Students (Politico)
Not Shaken, But Stirred
The Search for 007 Is Complete
Skimm’d by: Erika W. Smith and Maria Corpus
What's going on: Seven years after Daniel Craig turned in his 007 badge, the James Bond franchise has its new spy: Robert Pattinson. Whether you think of him as Edward Cullen, Batman, or The Odyssey villain Antinous (with the viral “Somebody get these beggars out of here” line), you definitely know him. According to The New York Times, five actors — Pattinson, Nicholas Hoult, Jack Lowden, Josh O’Connor, and Callum Turner — screen tested for Bond in late October. The process reportedly involved stunts and dialogue — and if Henry Cavill's 2005 Bond audition was anything to go by, maybe a semi-nude scene, too (and you thought your last job search was intense). Director Denis Villeneuve (who worked with Pattinson on Dune: Part Three) and the film’s producers made the final call. According to The Hollywood Reporter, Pattinson and the rest of the final five got the news on Sunday, one day before it went public. In a statement, Pattinson called stepping into 007’s Savile Row suits “the honor of a lifetime.”
Cue the discourse: A Bond casting always inspires snark and think pieces (remember the backlash against Daniel Craig?). As GQ puts it, Pattinson is “both a particularly inspired and obvious choice.” He’s another white dude, which will likely disappoint those who advocated for a Black and/or female Bond. Idris Elba and Regé-Jean Page were once rumored to be in the running, though the five who screen tested are all white men. Unlike Craig when he was cast, Pattinson is also already a household name, with roles in seemingly every big franchise. Yet his penchant for playing “weird little guys” in art house movies like The Lighthouse and Mickey 17 has made him beloved by cinephiles and suggests he can stand out from all the other Bonds before him. (Exactly how many? Test your knowledge in our quiz below.) We’ll have to wait a while before we see his take on Bond: The new 007 is unlikely to hit the big screen before 2028. That’s plenty of time to perfect your martini order.
Related: Idris Elba Says He Was Never Really in the Running To Play Bond (CNN)
Quick Hits
🍽️ If you want to save the complicated cooking for next week, here are nine hearty winter recipes that are filling and simple. Sign us up for the mushroom risotto.
🎢 Mattel announced that its forthcoming theme park will have a Barbie dreamhouse-inspired hotel with a giant pink tower. Come on, Barbie, let's go party.
🌱 What do garlic, broccoli, and bread all have in common? They are all potential, lesser-known triggers for bloating (and all for different reasons).
👟 File this under trends that can stay in the past: the wedge sneaker. Yes, millennials, this and five other controversial shoes are making a comeback.
👒 You need to see the enormous feathery hat Cardi B wore to the Baby2Baby Gala. That's one way to say, "I am the drama."
💅 ‘Tis the season for rich, textured nails. We're here for the velvety matte and fuzzy sweater trends.
Skimm This
Give us your best skimm:

We want your funniest take on this week's photo in 20 words or fewer. We'll pick our top three, you'll vote for your favorite in Thursday's Daily Skimm, and we'll announce the winner Friday.
This week: The Office's Kate Flannery stopped by The Jennifer Hudson Show to support her real-life bestie, Jane Lynch. Somewhere, a sitcom writer just got an idea.
What I’m Keeping Tabs On

Ali here, Senior Commerce Director. As we inch closer to my team’s biggest event of the year (Cyber Week), I've started a list of things I plan to buy. My wallet is currently placed out of reach until then, but here’s what I’ve queued up so far:
The perfect button-down. I’ve watched too many reels on how to button one in a cool way, so consider me influenced.
Sunglasses I can run in. When you spend over $89, you get 20% off with code SAVINGS20.
The holiday sweater I want to wear to Christmas dinner.
The insoles I’m praying will solve my current foot pain. I’ve upped my daily step count, but boy do I feel it.
KNOW IT ALL
How many actors have portrayed James Bond since the first movie in 1962?

SPONSORED BY ELI LILLY AND COMPANY
Wake-Up Call
This promotional information is intended for US Residents ages 18 and older.
Click here to view Indications and Safety Summary with Warnings.
Shaquille O’Neal has always played big. But he was also exhausted for way longer than he let on due to loud snoring, choking, and gasping for air while sleeping.
Turns out, those can be signs of moderate-to-severe obstructive sleep apnea (OSA), and he’s one of an estimated 24 million affected adults in the US, many of whom are living with obesity.
That’s why the NBA legend takes Zepbound® (tirzepatide), the first and only prescription medicine for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound is used along with a reduced-calorie diet and increased physical activity. If any of this sounds familiar, it may be worth a conversation with a doctor.
INDICATIONS AND SAFETY SUMMARY WITH WARNINGS
Zepbound® (ZEHP-bownd) is an injectable prescription medicine used with a reduced-calorie diet and increased physical activity to help adults with:
obesity, or some adults with overweight who also have weight-related medical problems, to lose excess body weight and keep the weight off.
moderate-to-severe obstructive sleep apnea (OSA) and obesity to improve their OSA.
Zepbound contains tirzepatide and should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines. It is not known if Zepbound is safe and effective for use in children.
Warnings - Zepbound may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.
• Do not use Zepbound if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).
• Do not use Zepbound if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Do not use Zepbound if you have had a serious allergic reaction to tirzepatide or any of the ingredients in Zepbound.
KwikPen®: Do not share your KwikPen with other people, even if the pen needle has been changed. You may give other people a serious infection or get a serious infection from them.
Zepbound may cause serious side effects, including:
Severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Zepbound. Tell your healthcare provider if you have stomach problems that are severe or will not go away.
Dehydration leading to kidney problems. Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away.
Gallbladder problems. Gallbladder problems have happened in some people who use Zepbound. Tell your healthcare provider right away if you get symptoms of gallbladder problems, which may include pain in your upper stomach (abdomen), fever, yellowing of skin or eyes (jaundice), or clay-colored stools.
Inflammation of the pancreas (pancreatitis). Stop using Zepbound and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. You may feel the pain from your abdomen to your back.
Serious allergic reactions. Stop using Zepbound and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, or very rapid heartbeat.
Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Zepbound with medicines that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, mood changes, hunger, weakness or feeling jittery.
Changes in vision in patients with type 2 diabetes. Tell your healthcare provider if you have changes in vision during treatment with Zepbound.
Food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). Zepbound may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your healthcare providers that you are taking Zepbound before you are scheduled to have surgery or other procedures.
Common side effects
The most common side effects of Zepbound include nausea, diarrhea, vomiting, constipation, stomach (abdominal) pain, indigestion, injection site reactions, feeling tired, allergic reactions, belching, hair loss, and heartburn. These are not all the possible side effects of Zepbound. Talk to your healthcare provider about any side effect that bothers you or doesn’t go away.
Tell your doctor if you have any side effects. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.
Before using Zepbound
• Your healthcare provider should show you how to use Zepbound before you use it for the first time.
• Talk to your healthcare provider about low blood sugar and how to manage it. Tell your healthcare provider if you are taking medicines to treat diabetes including an insulin or sulfonylurea.
• If you take birth control pills by mouth, talk to your healthcare provider before you use Zepbound. Birth control pills may not work as well while using Zepbound. Your healthcare provider may recommend another type of birth control for 4 weeks after you start Zepbound and for 4 weeks after each increase in your dose of Zepbound.
Review these questions with your healthcare provider:
❑ Do you have other medical conditions, including problems with your pancreas, or severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems digesting food?
❑ Do you take diabetes medicines, such as insulin or sulfonylureas?
❑ Do you have a history of diabetic retinopathy?
❑ Are you scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation)?
❑ Do you take any other prescription medicines or over-the-counter drugs, vitamins, or herbal supplements?
❑ Are you pregnant, plan to become pregnant, breastfeeding, or plan to breastfeed? Zepbound may harm your unborn baby. Tell your healthcare provider if you become pregnant while using Zepbound. Zepbound may pass into your breast milk. You should talk with your healthcare provider about the best way to feed your baby while using Zepbound.
• Pregnancy Exposure Registry: There is a pregnancy exposure registry for women who have taken Zepbound during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. Talk to your healthcare provider about how you can take part in this registry, or you may call 1-844-524-0039 or email at MILEregistry@thermofisher.com or visit https://pregnancyregistry.lilly.com/zepbound.
How to take
Read the Instructions for Use that come with Zepbound.
Use Zepbound exactly as your healthcare provider says.
Use Zepbound with a reduced-calorie diet and increased physical activity.
Inject Zepbound under the skin (subcutaneously) of your stomach (abdomen), thigh, or have another person inject in the back of the upper arm. Do not inject ZEPBOUND into a muscle (intramuscularly) or vein (intravenously).
Use Zepbound 1 time each week, at any time of the day.
Change (rotate) your injection site with each weekly injection. Do not use the same site for each injection.
If you take too much Zepbound, call your healthcare provider, call the Poison Help line at 1-800-222-1222 or go to the nearest hospital emergency room right away.
Zepbound is approved as a 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg injection.
Learn more
Zepbound is a prescription medicine. For more information, call 1-800-LillyRx (1-800-545-5979) or go to www.zepbound.lilly.com.
This summary provides basic information about Zepbound but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare provider about Zepbound and how to take it. Your healthcare provider is the best person to help you decide if Zepbound is right for you.
ZP CON BS 01SEP2026
Zepbound®, its delivery device base and KwikPen® are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
CMAT-45347 10/2026
© Lilly USA, LLC 2026. All rights reserved.
Do not reply to this email. If you have a medical emergency please call 911 or go to your nearest medical facility. If you have a question about a Lilly product, please call 1-800-LillyRx (1-800-545-5979)
PS: This is a sponsored post by Eli Lilly and Company. All rights reserved.
Live Smarter
Sign up for the Daily Skimm email newsletter. Delivered to your inbox every morning and prepares you for your day in minutes.

